AAAAAA
Results:
1-14
|
Results: 14
Authors:
Blaise, D
Maraninchi, D
Michallet, M
Reiffers, J
Jouet, JP
Milpied, N
Devergie, A
Attal, M
Sotto, JJ
Kuentz, M
Ifrah, N
Duriac, C
Bordigoni, P
Gratecos, N
Guilhot, F
Guyotat, D
Gluckman, E
Vernant, JP
Citation: D. Blaise et al., Long-term follow-up of a randomized trial comparing the combination of cyclophosphamide with total body irradiation or busulfan as conditioning regimen for patients receiving HLA-identical marrow grafts for acute myeloblastic leukemia in first complete remission, BLOOD, 97(11), 2001, pp. 3669-3671
Authors:
Boudard, D
Sordet, O
Vasselon, C
Revol, V
Bertheas, MF
Freyssenet, D
Viallet, A
Piselli, S
Guyotat, D
Campos, L
Citation: D. Boudard et al., Expression and activity of caspases 1 and 3 in myelodysplastic syndromes, LEUKEMIA, 14(12), 2000, pp. 2045-2051
Authors:
Michallet, M
Thiebaut, A
Philip, I
Charrin, C
Vigouroux, C
Thomas, X
Bilger, K
Belhabri, A
Guyotat, D
Corront, B
Salles, B
Dumontet, C
Peaud, PY
Vilque, JP
Devidas, A
Fiere, D
Citation: M. Michallet et al., Late autologous transplantation in chronic myelogenous leukemia with peripheral blood progenitor cells mobilized by G-CSF and interferon-alpha, LEUKEMIA, 14(12), 2000, pp. 2064-2069
Authors:
Prudhomme-Lacroix, F
Jaubert, J
Mosnier, JF
Guyotat, D
Citation: F. Prudhomme-lacroix et al., Hodgkin's disease of the tonsil: clinical, histological, immunophenotypical features and association with Epstein-Barr virus, PRESSE MED, 29(17), 2000, pp. 935-938
Authors:
Harousseau, JL
Witz, B
Lioure, B
Hunault-Berger, M
Desablens, B
Delain, M
Guilhot, F
Le Prise, PY
Abgrall, JF
Deconinck, E
Guyotat, D
Vilque, JP
Casassus, P
Tournilhac, O
Audhuy, B
Solary, E
Citation: Jl. Harousseau et al., Granulocyte colony-stimulating factor after intensive consolidation chemotherapy in acute myeloid leukemia: Results of a randomized trial of the Groupe Ouest-Est Leucemies Aigues Myeloblastiques, J CL ONCOL, 18(4), 2000, pp. 780-787
Authors:
Moukahal, MA
Jaubert, J
Guyotat, D
Citation: Ma. Moukahal et al., Infectious complications in patients with common variable immunoglobulin deficiency. A retrospective case study., MED MAL INF, 30(2), 2000, pp. 81-86
Authors:
Michallet, M
Thomas, X
Vernant, JP
Kuentz, M
Socie, G
Esperou-Bourdeau, H
Milpied, N
Blaise, D
Rio, B
Reiffers, J
Jouet, JP
Cahn, JY
Bourhis, JH
Lioure, B
Leporrier, M
Sotto, JJ
Souillet, G
Sutton, L
Bordigoni, P
Dreyfus, F
Tilly, H
Gratecos, N
Attal, M
Leprise, PY
Demeocq, F
Michel, G
Buzyn, A
Delmas-Marsalet, B
Bernaudin, F
Ifrah, N
Sadoun, A
Guyotat, D
Cavazzana-Cavo, M
Caillot, D
De Revel, T
Vannier, JP
Baruchel, A
Fegueux, N
Tanguy, ML
Thiebaut, A
Belhabri, A
Archimbaud, E
Citation: M. Michallet et al., Long-term outcome after allogeneic hematopoietic stem cell transplantationfor advanced stage acute myeloblastic leukemia: a retrospective study of 379 patients reported to the Societe Francaise de Greffe de Moelle (SFGM), BONE MAR TR, 26(11), 2000, pp. 1157-1163
Authors:
Michallet, M
Tanguy, ML
Socie, G
Thiebaut, A
Belhabri, A
Milpied, N
Reiffers, J
Kuentz, M
Cahn, JY
Blaise, D
Demeocq, F
Jouet, JP
Michallet, AS
Ifrah, N
Vilmer, E
Molina, L
Michel, G
Lioure, B
Cavazzana-Calvo, M
Pico, JL
Sadoun, A
Guyotat, D
Attal, M
Cure, H
Bordigoni, P
Sutton, L
Buzyn-Veil, A
Tilly, M
Leporrier, M
Fegueux, N
Dreyfus, F
Rio, B
Lutz, P
Vernant, JP
Citation: M. Michallet et al., Second allogeneic haematopoietic stem cell transplantation in relapsed acute and chronic leukaemias for patients who underwent a first allogeneic bone marrow transplantation: a survey of the Societe Francaise de Greffe de Moelle (SFGM), BR J HAEM, 108(2), 2000, pp. 400-407
Authors:
Campos, L
Sabido, O
Viallet, A
Vasselon, C
Guyotat, D
Citation: L. Campos et al., Expression of apoptosis-controlling proteins in acute leukemia cells, LEUK LYMPH, 33(5-6), 1999, pp. 499-509
Authors:
Guyotat, D
Wahbi, K
Viallet, A
Piselli, S
Campos, L
Citation: D. Guyotat et al., Selection of BCR/ABL-negative stem cells from marrow or blood of patients with chronic myeloid leukemia, LEUKEMIA, 13(7), 1999, pp. 991-998
Authors:
Michallet, M
Perrin, MC
Belhabri, A
Molina, L
Nicolini, F
Tigaud, JD
Sotto, JJ
Guyotat, D
Fiere, D
Archimbaud, E
Citation: M. Michallet et al., Impact of cyclosporine and methylprednisolone dose used for prophylaxis and therapy of graft-versus-host disease on survival and relapse after allogeneic bone marrow transplantation, BONE MAR TR, 23(2), 1999, pp. 145-150
Authors:
Tardy-Poncet, B
Tardy, B
Reynaud, J
Mahul, P
Mismetti, P
Mazet, E
Guyotat, D
Citation: B. Tardy-poncet et al., Efficacy and safety of danaparoid sodium (ORG 10172) in critically ill patients with heparin-associated thrombocytopenia, CHEST, 115(6), 1999, pp. 1616-1620
Authors:
Ifrah, N
Witz, F
Jouet, JP
Francois, S
Lamy, T
Linassier, C
Pignon, B
Berthou, C
Guyotat, D
Cahn, JY
Harousseau, JL
Citation: N. Ifrah et al., Intensive short term therapy with granulocyte-macrophage-colony stimulating factor support, similar to therapy for acute myeloblastic leukemia, does not improve overall results for adults with acute lymphoblastic leukemia, CANCER, 86(8), 1999, pp. 1496-1505
Authors:
Misery, L
Cambazard, F
Rimokh, R
Ghohestani, R
Magaud, JP
Gaudillere, A
Perrot, JL
Berard, F
Claudy, A
Guyotat, D
Schmitt, D
Vincent, C
Citation: L. Misery et al., Bullous pemphigoid associated with chronic B-cell lymphatic leukaemia: theanti-230-kDa autoantibody is not synthesized by leukaemic cells, BR J DERM, 141(1), 1999, pp. 155-157
Risultati:
1-14
|